Preterm Premature Rupture of Membrane
22
2
4
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
23%
5 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (22)
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support
Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane
Trans-perineal Ultrasound in Assessment of PPROMs
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
MIRACLE of LIFE Study
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial
Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes
Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
Prediction of the Onset of Term and Preterm Labour
Cerclage After Full Dilatation Caesarean Section
Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
Domiciliary Versus Hospital Management of PPROM
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
Bed Rest After Preterm Premature Rupture of the Membranes